Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study

BACKGROUND: Monoclonal antibodies (mAbs) and antivirals have been approved for early therapy of coronavirus disease (COVID-19), however, in the real-life setting, there are difficulties to prescribe these therapies within few days from symptom onset as recommended, and effectiveness of combined use...

Descripción completa

Detalles Bibliográficos
Autores principales: Scaglione, Vincenzo, Rotundo, Salvatore, Marascio, Nadia, De Marco, Carmela, Lionello, Rosaria, Veneziano, Claudia, Berardelli, Lavinia, Quirino, Angela, Olivadese, Vincenzo, Serapide, Francesca, Tassone, Bruno, Morrone, Helen Linda, Davoli, Chiara, La Gamba, Valentina, Bruni, Andrea, Cesana, Bruno Mario, Matera, Giovanni, Russo, Alessandro, Costanzo, Francesco Saverio, Viglietto, Giuseppe, Trecarichi, Enrico Maria, Torti, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583059/
https://www.ncbi.nlm.nih.gov/pubmed/36266619
http://dx.doi.org/10.1186/s12879-022-07774-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583059/
https://www.ncbi.nlm.nih.gov/pubmed/36266619
http://dx.doi.org/10.1186/s12879-022-07774-9

Ejemplares similares